Table of Content


Chapter 1. Global Adult Vaccine Market Executive Summary
1.1. Global Adult Vaccine Market Size & Forecast (2022–2032)
1.2. Regional Summary
1.3. Segmental Summary
1.3.1. By Type
1.3.2. By Application
1.4. Key Trends
1.5. Recession Impact
1.6. Analyst Recommendation & Conclusion
Chapter 2. Global Adult Vaccine Market Definition and Research Assumptions
2.1. Research Objective
2.2. Market Definition
2.3. Research Assumptions
2.3.1. Inclusion & Exclusion
2.3.2. Limitations
2.3.3. Supply Side Analysis
2.3.3.1. Availability
2.3.3.2. Infrastructure
2.3.3.3. Regulatory Environment
2.3.3.4. Market Competition
2.3.3.5. Economic Viability (Consumer’s Perspective)
2.3.4. Demand Side Analysis
2.3.4.1. Regulatory Frameworks
2.3.4.2. Technological Advancements
2.3.4.3. Environmental Considerations
2.3.4.4. Consumer Awareness & Acceptance
2.4. Estimation Methodology
2.5. Years Considered for the Study
2.6. Currency Conversion Rates
Chapter 3. Global Adult Vaccine Market Dynamics
3.1. Market Drivers
3.1.1. Aging populations and rising chronic disease burden
3.1.2. Pandemic-driven awareness and stronger immunization policies
3.1.3. Expanding international travel and region-specific vaccine demand
3.2. Market Challenges
3.2.1. High vaccine development and distribution costs
3.2.2. Cold-chain logistics and infrastructural gaps in low-income regions
3.2.3. Vaccine hesitancy and uneven coverage rates
3.3. Market Opportunities
3.3.1. Advances in novel platforms (mRNA, adjuvants, needle-free delivery)
3.3.2. Digital health tools and targeted awareness campaigns
3.3.3. Inclusion of adult vaccines in national immunization schedules
Chapter 4. Global Adult Vaccine Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model
4.1.7. Porter’s 5 Force Impact Analysis
4.2. PESTEL Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.2.5. Environmental
4.2.6. Legal
4.3. Top Investment Opportunity
4.4. Top Winning Strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion
Chapter 5. Global Adult Vaccine Market Size & Forecasts by Type 2022–2032
5.1. Segment Dashboard
5.2. Global Adult Vaccine Market: Type Revenue Trend Analysis, 2022 & 2032 (USD Million/Billion)
5.2.1. Influenza Vaccines
5.2.2. Pneumococcal Vaccines
5.2.3. Hepatitis Vaccines
5.2.4. Zoster Vaccines
5.2.5. Meningococcal Vaccines
5.2.6. HPV Vaccines
5.2.7. DTP Vaccines
5.2.8. Others
Chapter 6. Global Adult Vaccine Market Size & Forecasts by Application 2022–2032
6.1. Segment Dashboard
6.2. Global Adult Vaccine Market: Application Revenue Trend Analysis, 2022 & 2032 (USD Million/Billion)
6.2.1. Infectious Diseases
6.2.2. Travel Vaccines
6.2.3. Health Maintenance
Chapter 7. Global Adult Vaccine Market Size & Forecasts by Region 2022–2032
7.1. North America Adult Vaccine Market
7.1.1. U.S. Adult Vaccine Market
7.1.1.1. Type breakdown size & forecasts, 2022–2032
7.1.1.2. Application breakdown size & forecasts, 2022–2032
7.1.2. Canada Adult Vaccine Market
7.2. Europe Adult Vaccine Market
7.2.1. UK Adult Vaccine Market
7.2.2. Germany Adult Vaccine Market
7.2.3. France Adult Vaccine Market
7.2.4. Spain Adult Vaccine Market
7.2.5. Italy Adult Vaccine Market
7.2.6. Rest of Europe Adult Vaccine Market
7.3. Asia Pacific Adult Vaccine Market
7.3.1. China Adult Vaccine Market
7.3.2. India Adult Vaccine Market
7.3.3. Japan Adult Vaccine Market
7.3.4. Australia Adult Vaccine Market
7.3.5. South Korea Adult Vaccine Market
7.3.6. Rest of Asia Pacific Adult Vaccine Market
7.4. Latin America Adult Vaccine Market
7.4.1. Brazil Adult Vaccine Market
7.4.2. Mexico Adult Vaccine Market
7.4.3. Rest of Latin America Adult Vaccine Market
7.5. Middle East & Africa Adult Vaccine Market
7.5.1. Saudi Arabia Adult Vaccine Market
7.5.2. South Africa Adult Vaccine Market
7.5.3. Rest of Middle East & Africa Adult Vaccine Market
Chapter 8. Competitive Intelligence
8.1. Key Company SWOT Analysis
8.1.1. GlaxoSmithKline plc
8.1.2. Pfizer Inc.
8.1.3. Merck & Co., Inc.
8.2. Top Market Strategies
8.3. Company Profiles
8.3.1. GlaxoSmithKline plc
8.3.1.1. Key Information
8.3.1.2. Overview
8.3.1.3. Financial (Subject to Data Availability)
8.3.1.4. Product Summary
8.3.1.5. Market Strategies
8.3.2. Pfizer Inc.
8.3.3. Merck & Co., Inc.
8.3.4. Sanofi
8.3.5. Novavax, Inc.
8.3.6. Johnson & Johnson
8.3.7. Bavarian Nordic
8.3.8. Serum Institute of India Pvt. Ltd.
8.3.9. CSL Limited
8.3.10. Emergent BioSolutions Inc.
8.3.11. Astellas Pharma Inc.
8.3.12. Takeda Pharmaceutical Company Limited
8.3.13. Bharat Biotech
8.3.14. Mitsubishi Tanabe Pharma Corporation
8.3.15. Daiichi Sankyo Company, Limited
Chapter 9. Research Process
9.1. Research Process
9.1.1. Data Mining
9.1.2. Analysis
9.1.3. Market Estimation
9.1.4. Validation
9.1.5. Publishing
9.2. Research Attributes



List of Figures

List of Figures
FIG 1. Global Adult Vaccine market, research methodology
FIG 2. Global Adult Vaccine market, market estimation techniques
FIG 3. Global market size estimates & forecast methods
FIG 4. Global Adult Vaccine market, key trends 2023
FIG 5. Global Adult Vaccine market, growth prospects 2022–2032
FIG 6. Global Adult Vaccine market, Porter’s 5 force model
FIG 7. Global Adult Vaccine market, PESTEL analysis
FIG 8. Global Adult Vaccine market, value chain analysis
FIG 9. Global Adult Vaccine market by segment, 2022 & 2032 (USD Million/Billion)
FIG 10. Global Adult Vaccine market by segment, 2022 & 2032 (USD Million/Billion)
FIG 11. Global Adult Vaccine market by segment, 2022 & 2032 (USD Million/Billion)
FIG 12. Global Adult Vaccine market by segment, 2022 & 2032 (USD Million/Billion)
FIG 13. Global Adult Vaccine market by segment, 2022 & 2032 (USD Million/Billion)
FIG 14. Global Adult Vaccine market, regional snapshot 2022 & 2032
FIG 15. North America Adult Vaccine market 2022 & 2032 (USD Million/Billion)
FIG 16. Europe Adult Vaccine market 2022 & 2032 (USD Million/Billion)
FIG 17. Asia Pacific Adult Vaccine market 2022 & 2032 (USD Million/Billion)
FIG 18. Latin America Adult Vaccine market 2022 & 2032 (USD Million/Billion)
FIG 19. Middle East & Africa Adult Vaccine market 2022 & 2032 (USD Million/Billion)
FIG 20. Global Adult Vaccine market, company market share analysis (2023)

List of Tables

List of Tables
TABLE 1. Global Adult Vaccine market, report scope
TABLE 2. Global Adult Vaccine market estimates & forecasts by Region 2022–2032 (USD Million/Billion)
TABLE 3. Global Adult Vaccine market estimates & forecasts by Type 2022–2032 (USD Million/Billion)
TABLE 4. Global Adult Vaccine market estimates & forecasts by Application 2022–2032 (USD Million/Billion)
TABLE 5. Global Adult Vaccine market by segment, estimates & forecasts, 2022–2032 (USD Million/Billion)
TABLE 6. Global Adult Vaccine market by region, estimates & forecasts, 2022–2032 (USD Million/Billion)
TABLE 7. U.S. Adult Vaccine market estimates & forecasts, 2022–2032 (USD Million/Billion)
TABLE 8. U.S. Adult Vaccine market estimates & forecasts by segment, 2022–2032 (USD Million/Billion)
TABLE 9. Canada Adult Vaccine market estimates & forecasts, 2022–2032 (USD Million/Billion)
TABLE 10. Canada Adult Vaccine market estimates & forecasts by segment, 2022–2032 (USD Million/Billion)
TABLE 11. UK Adult Vaccine market estimates & forecasts, 2022–2032 (USD Million/Billion)
TABLE 12. Germany Adult Vaccine market estimates & forecasts, 2022–2032 (USD Million/Billion)
TABLE 13. France Adult Vaccine market estimates & forecasts, 2022–2032 (USD Million/Billion)
TABLE 14. Spain Adult Vaccine market estimates & forecasts, 2022–2032 (USD Million/Billion)
TABLE 15. Italy Adult Vaccine market estimates & forecasts, 2022–2032 (USD Million/Billion)
TABLE 16. Brazil Adult Vaccine market estimates & forecasts, 2022–2032 (USD Million/Billion)
TABLE 17. Mexico Adult Vaccine market estimates & forecasts, 2022–2032 (USD Million/Billion)
TABLE 18. China Adult Vaccine market estimates & forecasts, 2022–2032 (USD Million/Billion)
TABLE 19. India Adult Vaccine market estimates & forecasts, 2022–2032 (USD Million/Billion)
TABLE 20. Japan Adult Vaccine market estimates & forecasts, 2022–2032 (USD Million/Billion)